02/25/2019
https://congress.gov...
"I both understand and support that goal, but I also want to ensure that in seeking to accelerate drug approval that we do not expose patients to unnecessary and unacceptable risks."
"I want to make sure we maximize drug safety efforts and that we do not encourage expedited FDA approval if doing so would jeopardize that goal."
"I strongly support the development of drugs to enhance therapeutic options for patients with rare diseases."
"I wanted to point out and thank you for the fact that 54 million Americans were provided at least one preventive service in 2011 through their private health insurance plan for no cost."